Author Affiliations: Dr Fontanarosa is Executive Deputy Editor and Dr DeAngelis is Editor-in-Chief, JAMA.
In this issue of JAMA, Ascherio and colleagues1 request retraction of their article titled “Multiple Sclerosis and Epstein-Barr Virus,”2 which was published in the March 26, 2003, issue. As the authors explain in their letter to the editor,1 an inadvertent error occurred in sorting of one of the data files used in their nested case-control study. This error led to incorrect matching of the serologic findings from the laboratory analysis and the clinical data, including incorrect assignment of several dates of blood collection. Once the authors discovered this error and reanalyzed the data with the correctly matched samples, it was apparent that many of the data points reported in the original article were incorrect. Even though the main finding of the study was essentially unchanged, correcting the data errors completely would have required publication of an extensive correction, including republication of correct data points in the abstract and throughout the text, along with republication of corrected tables and figures.
In our view, publishing such an extensive correction would have been more confusing than clarifying. Therefore, to correct the literature and to present the findings as clearly as possible, the authors submitted a manuscript with the properly matched data, along with an updated analysis based on the corrected blood collection dates. This newly submitted manuscript has been peer reviewed and revised satisfactorily and is published in this issue of JAMA.3 This article presents the findings of the corrected data and analyses clearly and demonstrates the significant association between anti–Epstein-Barr virus nuclear antigen titers and risk of multiple sclerosis as originally reported, along with evidence that this association is modified by age.
Retractions of articles from major medical journals are unusual events but have occurred based on serious grounds, such as falsification and fabrication of data4 or other major ethical breaches, such as misrepresentation.5 Publication of incorrect data, as occurred with the article being retracted from JAMA, is also a serious issue. However, in this case, the errors that led to the retraction were unintentional, and the authors have been forthcoming in disclosing this error and diligent in ensuring that the most accurate information from this study is communicated clearly to clinicians, physician-scientists, and other researchers. This is a good example of an optimal outcome when inadvertent errors occur in biomedical research; after all, to err is human, to correct, almost divine.
Editorials represent the opinions of the authors and JAMA and not those of the American Medical Association.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.